Anthony Nigro | Researchain

Archive Network Publication Hotspot Collaboration

Hotspot

Bubble
[Coming Soon]

Cloud

Mosaic
[Coming Soon]

Archive | 2005

6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors

Lee D. Arnold; Cara Cesario; Heather Coate; Andrew Philip Crew; Hanqing Dong; Kenneth Foreman; Ayako Honda; Radoslaw Laufer; An-Hu Li; Kristen Michelle Mulvihill; Mark J. Mulvihill; Anthony Nigro; Bijoy Panicker; Arno G. Steinig; Yingchuan Sun; Qinghua Weng; Douglas S. Werner; Michael J. Wyle; Tao Zhang

Bioorganic & Medicinal Chemistry | 2008

Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors

Mark J. Mulvihill; Qun-Sheng Ji; Heather Coate; Andrew Cooke; Hanqing Dong; Lixin Feng; Kenneth Foreman; Maryland Rosenfeld-Franklin; Ayako Honda; Gilda Mak; Kristen Michelle Mulvihill; Anthony Nigro; Matthew O’Connor; Caroline Pirrit; Arno G. Steinig; Kam W. Siu; Kathryn M. Stolz; Yingchuan Sun; Paula A. R. Tavares; Yan Yao; Neil W. Gibson

Archive | 2004

Imidazo[1,5-a]pyrazine tyrosine kinase inhibitors

Patricia Anne Beck; Cara Cesario; Matthew Cox; Hanqing Dong; Kenneth Foreman; Mark J. Mulvihill; Anthony Nigro; Lydia Saroglou; Arno G. Steinig; Yingchuan Sun; Qinghua Weng; Douglas S. Werner; Robin D. Wilkes; Jonathan Williams

Bioorganic & Medicinal Chemistry Letters | 2007

1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitors

Mark J. Mulvihill; Qun-Sheng Ji; Doug Werner; Patricia Anne Beck; Cara Cesario; Andrew Cooke; Matthew Cox; Andrew P. Crew; Hanqing Dong; Lixin Feng; Kenneth Foreman; Gilda Mak; Anthony Nigro; Matthew O’Connor; Lydia Saroglou; Kathryn M. Stolz; Izabela Sujka; Brian Volk; Qinghua Weng; Robin Wilkes

Archive | 2004

Imidazopyrazine tyrosine kinase inhibitors

Synthesis | 2010

One-Pot FriedländerQuinoline Synthesis: Scope and Limitations

An-Hu Li; David J. Beard; Heather Coate; Ayako Honda; Mridula Kadalbajoo; Andrew Kleinberg; Radoslaw Laufer; Kristen Michelle Mulvihill; Anthony Nigro; Pawan Rastogi; Dan Sherman; Kam W. Siu; Arno G. Steinig; Ti Wang; Doug Werner; Andrew P. Crew; Mark J. Mulvihill

Journal of Organic Chemistry | 2004

Regio- and Stereospecific Syntheses of syn- and anti-1,2-Imidazolylpropylamines from the Reaction of 1,1‘-Carbonyldiimidazole with syn- and anti-1,2-Amino Alcohols

Mark J. Mulvihill; Cara Cesario; Vanessa Smith; Patricia Anne Beck; Anthony Nigro

Bioorganic & Medicinal Chemistry Letters | 2005

Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines as retinoic acid metabolic blocking agents (RAMBAs)

Mark J. Mulvihill; Julie L.C. Kan; Patricia Anne Beck; Mark Bittner; Cara Cesario; Andrew Cooke; David M. Keane; Anthony Nigro; Christy Nillson; Vanessa Smith; Mary Srebernak; Feng-Lei Sun; Michael Vrkljan; Shannon L. Winski; Arlindo L. Castelhano; David L. Emerson; Neil W. Gibson

Archive | 2004

Naphthylene derivatives as cytochrome P450 inhibitors

Vanessa Smith; Anthony Nigro; Mark J. Mulvihill; Cara Cesario; Patricia Anne Beck; Arlindo L. Castelhano

Bioorganic & Medicinal Chemistry Letters | 2006

3-[6-(2-Dimethylamino-1-imidazol-1-yl-butyl)-naphthalen-2-yloxy]-2,2-dimethyl-propionic acid as a highly potent and selective retinoic acid metabolic blocking agent

Mark J. Mulvihill; Julie L.C. Kan; Andrew Cooke; Shripad V. Bhagwat; Patricia Anne Beck; Mark Bittner; Cara Cesario; David M. Keane; Viorica Lazarescu; Anthony Nigro; Christy Nillson; Bijoy Panicker; Vanessa Smith; Mary Srebernak; Feng-Lei Sun; Matthew O’Connor; Suzanne Russo; Gia Fischetti; Michael Vrkljan; Shannon L. Winski; Arlindo L. Castelhano; David L. Emerson; Neil W. Gibson

Explore More